Prevalence of Cardiac Amyloidosis in Patients Undergoing Surgery for Lumbar Spinal Stenosis.
Not Applicable
Recruiting
- Conditions
- Spinal StenosisCardiac Amyloidosis
- Interventions
- Diagnostic Test: DPD scintigraphy
- Registration Number
- NCT05701397
- Lead Sponsor
- Steen Hvitfeldt Poulsen
- Brief Summary
Patients undergoing surgery for lumbar spinal stenosis will have biopsies of the ligamentum flavum sent to the department of pathology for histologic screening.
If the ligament biopsy contains amyloid, patients will receive an echocardiogram, an ecg, biomarker testing, and a bone tracer scintigraphy diagnostic of cardiac amyloidosis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
- Scheduled for surgery for lumbar spinal stenosis
- Age > 65 years
- Informed written consent
Exclusion Criteria
- Known amyloidosis
- Myelomatosis
- Monoclonal gammopathy of unknown significance, MGUS
- Morbus Waldenstrøm
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Study group DPD scintigraphy Patients undergoing surgery for lumbar spinal stenosis. Patients will have a biopsy taken from the ligamentum flavum and test for the presence of amyloid. Patients with amyloid in the ligamentum flavum will be referred for a DPD scintigraphy.
- Primary Outcome Measures
Name Time Method Diagnosis of cardiac amyloidosis 1 year DPD scintigraphy with a Perugini Grade 2 og higher.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Department of Cardiology, Aarhus University Hospital
🇩🇰Aarhus N, Denmark